NEUROSCIENCE20
[ Brain, Spine and Mental Health ]
A Global Platform for NeuroTech (PharmaTech, MedTech, CellTech, BioTech, AITech, and FinTech) Policy and Innovation
Neuroscience20 is a joint initiative of SBMT and WBMF, advancing brain, spine, and mental health through science, policy, technology, education, global collaboration, and patient impact.
13th Annual Neuroscience20 Summit
The Countdown to Miami
Sunday, December 13, 2026 • 8:00 AM EST • Miami, Florida
The N20 Miami Summit has begun.
Science, policy and nonprofit mission working together
Neuroscience20 is a joint initiative of the Society for Brain Mapping and Therapeutics and the World Brain Mapping Foundation. SBMT provides the scientific, clinical, engineering, innovation and policy leadership. WBMF supports the 501(c)(3) nonprofit mission of education, global collaboration, patient impact, public awareness and public-benefit brain health advancement.
What Is the G20?
Visit the Official G20 WebsiteThe Group of Twenty (G20) is an intergovernmental forum that brings together the world's major economies to coordinate dialogue on economic stability, sustainable development, innovation and shared global challenges.
These engagement groups provide structured stakeholder input and policy recommendations to the G20 process.
Neuroscience20 (N20)
Neuroscience20 brings brain, spine and mental health into the global policy conversation, connecting policymakers, scientists, clinicians, engineers, investors and industry leaders around translation, innovation and clinical impact.
Launched in 2014 by the Society for Brain Mapping & Therapeutics, N20 is now presented as a joint SBMT and WBMF initiative. It aligns with the U.S. BRAIN Initiative and works across neuroscience, neurotechnology, AI, therapeutics, education, global collaboration, patient impact and health policy.
N20 Media
Selected N20 archive videos for delegates, policymakers, researchers and invited participants.


BRAIN HEALTH
BLUEPRINT GEMINI AI PODCAST
OFFICIAL N20 POLICY OBJECTIVES
Goals of Neuroscience20
Global priorities for brain, spine and mental health.
Goals of Neuroscience20
Global priorities for brain, spine and mental health.
- 01
Build a global alliance for brain, spine and mental health/illness.
- 02
Encourage a consortium approach to research and development.
- 03
Advocate for global harmonization of related policies and standardization of data.
- 04
Encourage neuro-economic assessment of the future impact of disease, diagnostics and prevention.
- 05
Facilitate translation and commercialization of technologies across disciplines to rapidly identify and introduce next-generation therapeutics.
- 06
Advocate for unifying global regulations and guidelines on clinical trials and drug/device-combination discovery.
- 07
Advance innovation in brain, spine, and mental health through global partnerships and new funding initiatives across academia, industry, nonprofits, and government.
- 08
Integrate nanotechnology, artificial intelligence, virtual/augmented reality, supercomputing, multimodality brain mapping/imaging, cellular therapeutics, neurophotonics, and devices to fast-track innovation and reduce healthcare delivery costs.
- 09
Bring global brain and spine initiatives together to identify best clinical and basic-science practices and create a united front for effective therapeutics.
- 10
Set unified standards for training, prevention, care, and advanced therapeutics across the clinical neuroscience workforce.
- 11
Provide local, regional, and national capabilities to advance clinical neuroscience practice through advocacy and engagement with health ministries and government programs.
- 12
Advocate for global research and innovation funding for brain, spine, and mental health.
- 13
Facilitate investment and commercialization of neurotechnologies for brain, spine, and mental health/illness.
- 14
Educate professionals, patients, and families about the state of science, technology, innovation, and policy in clinical neuroscience.
- 15
Provide accurate, up-to-date resources and data to governments of G20 nations and beyond to support evidence-based clinical neuroscience policy.
- 16
Spread awareness and support prevention and intervention for mental and psychological health challenges, including PTSD, anxiety, stress, and suicide prevention.
N20 Summit Executive Leadership
The 2026 Neuroscience20 Summit brings together the senior leadership guiding the summit across medicine, science, policy, and technology.
President of the Neuroscience20 (N20) Summit
N20 Summit President
Founding Chairman, Director & CEO, SBMT
Babak Kateb MD, PhD
Full profile
Founding Chairman of the Board, Director, and CEO of the Society for Brain Mapping and Therapeutics, which he established in 2004 as a research fellow at USC’s Keck School of Medicine, Department of Neurosurgery, alongside Farzad Massoudi and Warren Grundfest. He also serves as President and Scientific Director of the World Brain Mapping Foundation, Director of the National Center for Nano-Bio-Electronics, and a director of the Brain Technology Innovation Park. He previously led research and development in neurosurgery at the City of Hope Comprehensive Cancer Center, where he pioneered a NASA-derived carbon nanotube technique for brain cancer immunotherapy that earned him a NASA Tech Brief Award. His ongoing collaborations with NASA/JPL and Los Alamos National Laboratory apply AI, augmented and virtual reality, and advanced ultrasonic technology to brain mapping and therapeutics. He has been recognized by then Vice President Biden, the Mayor of Los Angeles, and the Governor of California, received SBMT and WBMF’s Pioneer in Medicine Award in 2015, and edited the inaugural Textbook of Nanoneuroscience and Nanoneurosurgery and Neurophotonics and Brain Mapping.
Senior Executive Vice Chairman, SBMT
N20 Co-Founder
N20 Co-Founder & 11th President, Society for Brain Mapping and Therapeutics
Kuldeep Singh Sidhu PhD
Full profile
Dr. Kuldeep Singh Sidhu, PhD is a professor at UNSW Sydney and a researcher whose work has contributed to the development and translation of stem cell and regenerative medicine technologies. His academic career spans biomedical research, stem cell biology, tissue regeneration, and the advancement of therapeutic approaches for damaged and diseased tissues.
Dr. Sidhu is also the 11th President of the Society for Brain Mapping and Therapeutics, reflecting a long-standing commitment to interdisciplinary collaboration across neuroscience, medicine, biotechnology, and translational research. As a co-founder of the Neuroscience20 (N20) platform, he brings an international scientific perspective to the summit’s mission of connecting neuroscience research with healthcare innovation and global policy.
Senior Executive Leadership
Cancer Science & Developmental Neurobiology
Vicky Yamamoto PhD
Full profile
Dr. Vicky Yamamoto is a cancer scientist at the Keck School of Medicine of USC in the Department of Otolaryngology and Head and Neck Surgery. Before joining USC, she worked at Mount St. Mary’s College, The Scripps Research Institute, the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center, and the California Institute of Technology. She received her PhD in biochemistry and molecular biology from the Keck School of Medicine of USC. Her publications have appeared in major journals including Cell, Developmental Cell, Cell Reports, PLOS ONE, NeuroImage, and Oral Oncology, and she has written several book chapters. Her current research and expertise span developmental neurobiology, cell signal transduction, cancer stem cells, molecular targeted therapy, small-molecule screening for cancer treatment, tissue-bank development, and clinical trials. She also serves as Executive Director of the Society for Brain Mapping and Therapeutics.
24th President of SBMT
24th President, Society for Brain Mapping and Therapeutics
Stefano M. Sinicropi MD
Full profile
Dr. Stefano M. Sinicropi serves as the 24th President of the Society for Brain Mapping and Therapeutics, bringing together surgical excellence, executive leadership, innovation, and a deeply patient-centered vision for the future of brain, spine, and whole-person health.
He is a board-certified orthopedic spine surgeon and President and CEO of Midwest Spine & Brain Institute, where he leads a comprehensive orthopedic and neurosurgical spine practice serving patients across Minnesota and the Midwest. He has performed more than 4,000 spinal surgeries across complex spine care, including minimally invasive surgery, deformity, cervical pathology, tumors, and infection.
Since 2012, Dr. Sinicropi has served as President and CEO of Midwest Spine & Brain Institute, helping guide practice growth, physician recruitment, operational development, and healthcare partnerships. His professional interests also extend into regenerative and longevity medicine; he is the founder of Hypercharge Health and co-founder of InSitu Biologics. He is also the author of Wellness at the Speed of Light and an educator on regenerative medicine, longevity science, metabolic health, and the future of healthcare.
Dr. Sinicropi earned his MD from Columbia University College of Physicians and Surgeons, completed his orthopedic surgery residency at Columbia University, and completed the Kenton D. Leatherman Spine Fellowship at the University of Louisville. As SBMT’s 24th President, he brings a strong clinical and strategic voice to the Society’s mission across brain mapping, neurotechnology, therapeutics, spine care, regenerative medicine, education, and interdisciplinary collaboration.
Co-Chairs of the Local Organizing Committee
Co-Chair
Neuro-Oncology & Radiosurgery
Susan C. Pannullo MD, FAANS, FAAN, FCNS
Full profile
Susan C. Pannullo, MD, FAANS, FAAN, FCNS is a double board-certified neurologist and neurosurgeon with subspecialty expertise in neuro-oncology and stereotactic radiosurgery. Her career bridges medicine, neuroscience, and engineering, and she holds academic appointments in Neurosurgery at Columbia University in New York and Biomedical Engineering at Cornell University in Ithaca. As founder and leader of the New York Brain Tumor Project, Dr. Pannullo directed NewYork-Presbyterian/Weill Cornell Medicine’s Neuro-Oncology and Brain and Spine Radiosurgery programs for more than two decades. Her career has encompassed clinical care, translational research, education, clinical trials, biomedical innovation, and academic leadership. She is a recognized advocate for quality and patient safety and was named a 2026 Castle Connolly Top Doctor and Exceptional Woman in Medicine. Dr. Pannullo received her undergraduate degree with honors in Anthropology from Cornell University and her medical degree from Cornell University Medical College. Following an internship at Harvard/Beth Israel Medical Center, she completed residency training in Neurology at New York Hospital/Cornell Medical Center and an American Cancer Society fellowship in Neuro-Oncology at Memorial Sloan Kettering Cancer Center. She subsequently completed a second residency in Neurological Surgery at New York Hospital/Cornell and Memorial Sloan Kettering, becoming the program’s first female graduate. She is also a graduate of the Executive Leadership in Academic Medicine (ELAM) fellowship. Dr. Pannullo’s research and innovation interests include brain tumors, stereotactic radiosurgery, advanced imaging, biomedical engineering, and the development of novel technologies for neurological disease. Her early laboratory research at the National Institutes of Health included work with Nobel Laureate and medical anthropologist Carleton Gajdusek. She later served as a brain tumor clinical trials leader and Chair of a Cancer Institutional Review Board at Weill Cornell Medicine. She is also an inventor on a U.S. patent for mixed-reality systems designed to enhance stereotactic radiosurgery treatment planning. A committed educator and mentor, Dr. Pannullo received Weill Cornell Medicine’s Robert G. Schwager, MD ’67 Education Scholar Award. Her national leadership has included service on the Boards of Directors of the National Brain Tumor Society and the American Association of Neurological Surgeons. She serves as Chair of the Board of Trustees of The Washington Center in Washington, DC. Her South Florida activities include membership in the Miami Biotech Collective and participation in Biotech Miami, reflecting her growing engagement with the region’s neuroscience, biotechnology, and innovation community. Dr. Pannullo was recently elected to the Board of Directors of the Society for Brain Mapping and Therapeutics and serves as Co-Chair of the Local Organizing Committee for Neuroscience20 (N20) in Miami, bringing together her longstanding interests in neuroscience, biotechnology, engineering, education, and multidisciplinary innovation.
Co-Chair
Neurosurgery & Minimally Invasive Spine Surgery
Michael Y. Wang MD, MBA, FACS, FAANS
Full profile
Chief of Neurosurgery at the University of Miami Hospital, Professor with Tenure in the Departments of Neurological Surgery and Rehabilitation Medicine, and Spine Neurosurgery Fellowship Director at the University of Miami Miller School of Medicine. A Phi Beta Kappa graduate of Stanford University who earned both his BS and MD there, he completed his neurosurgery residency at USC and LA County General Hospital and a spine fellowship at the University of Miami under Barth Green and Allan Levi. He then served as Spine Program and Fellowship Director at USC before moving to Miami in 2007. A pioneer in minimally invasive spine surgery, he has held leadership roles across the AANS Board of Directors, the North American Spine Society, the Society of University Neurosurgeons, and the International Society for the Advancement of Spine Surgery. He sits on editorial boards including Neurosurgery, World Neurosurgery, and the Journal of Neurosurgery: Spine, and has helped patients ranging from complex multilevel revision cases to a young gunshot victim regain the ability to walk.
Key Opinion Leaders
Distinguished leaders and high-level invitees associated with the 2026 N20 Miami program.

Dr Patrick Soon-Shiong
Physician, surgeon, scientist, inventor, technologist and healthcare entrepreneur; Chairman and CEO of NantWorks, with work spanning cancer therapeutics, biotechnology and healthcare technology.
NantWorks ↗.png)
Dr Mehmet Oz
Cardiothoracic surgeon and CMS Administrator. He received his MD and MBA from the University of Pennsylvania and is Professor Emeritus at NewYork-Presbyterian/Columbia Medical Center. His N20 Miami participation remains listed as To Be Confirmed.
Official CMS profile ↗
Dr Robert J. Hariri
Surgeon, biomedical scientist and entrepreneur; Chairperson, Founder and CEO of Celularity and a pioneer in cellular and regenerative medicine.
Celularity profile ↗
Dr Kasif Nevzat Tarhan
Professor of Psychiatry and President/Rector of Üsküdar University, Istanbul, with leadership spanning psychiatry, neuropsychology, mental health, education and global neuroscience collaboration.
Üsküdar University ↗
Dr Denis Fedorenko
MD, PhD, DSc and Professor of Hematology and Stem Cell Therapy at the National Medical and Surgical Center named after N.I. Pirogov in Moscow, with expertise in autologous HSCT and autoimmune disease.
Professional profile ↗
Dr Shinichiro Akiyama
Medical oncologist and translational cancer researcher; Director of the Tokyo Cancer and Intractable Disease Support Center and Natural Medica Japan, with work spanning oncology, regenerative medicine and gene-editing approaches.
N20 Program Profile ↗
Mr Saeed Amidi
Founder and CEO of Plug and Play Tech Center, a global innovation platform connecting startups with corporations, investors, universities and public-sector organizations. He brings decades of experience in startup ecosystems, venture investment and early-stage innovation.
N20 Program Profile ↗
Dr Kevan Moshayedi
MD, FACS, physician, engineer and Founder and Managing Partner of Moshayedi Investment Group. He brings more than 30 years of experience building and scaling businesses in healthcare, MedTech, AI, advanced technology and telecommunications, with investments spanning Seed through Series D.
N20 Program Profile ↗
Prof Qifa Zhou
PhD, Zohrab A. Kaprielian Professor in Engineering and Professor of Biomedical Engineering and Ophthalmology at the University of Southern California. His work advances ultrasound transducers, photoacoustic and multimodal biomedical imaging, and medical technology innovation.
N20 Program Profile ↗N20 Admin Protocol Team
Executive protocol, on-ground coordination, accommodation, press, marketing and public-relations leadership for N20 Miami.

Dr. Ana Isabel Alves da Cunha
Dr. Ana Isabel is Director of the Membership Committee of the Society for Brain Mapping and Therapeutics Brazil (SBMT), Director of the Brazilian Epilepsy Federation, Director of International Events for SBMT, and CEO of Hangar 7 Eventos.
Full profile

Ms Arifa Kokab
M.MSc, MScEng, Exec. MBA
Arifa Kokab heads all Marketing and PR for Neuroscience20 Miami 2026 and will also participate as a panel speaker. A biomedical neuroscientist and neuromorphic AI engineer, she is Scientific Founder & CEO of The Neurobusiness Corporation and Intelliforge.AI, and Chair of the AI Computational Neuroscience Consortium at the Society for Brain Mapping and Therapeutics (SBMT).
Full profile

Mr Bryan Aroz
Hospitality professional with most of his career spent representing leading hotel brands in the Sales department in India. His experience handling corporate business has strengthened his growth potential, relationship management, and networking skills. His hospitality industry background has further supported the growth of his HelmsBriscoe business while maintaining relationships with domestic and international clients, and has given him a broader understanding of how the hospitality industry operates on an international platform.
Explore Bryan's HelmsBriscoe profile ↗
Ms Kortni Gilson
Kortni Gilson serves as Press Officer for Neuroscience20 Miami, a joint initiative of the Society for Brain Mapping and Therapeutics (SBMT) and the World Brain Mapping Foundation (WBMF). She is also Associate Director of Industry & Nonprofit Partnerships at WBMF, connecting healthcare, technology, nonprofit, philanthropic and advocacy organizations through partnership development, strategic communications and event outreach.
Full profile

Mayra Castañeda
Mayra Castañeda serves as a Program Officer and Research Intern with the Society for Brain Mapping and Therapeutics (SBMT), bringing a background in neurobiology and scientific research. Her academic research experience includes work with USC's Molecular and Computational Biology program, where she developed laboratory skills, including expertise in the dissection of Drosophila melanogaster, an important model organism in biological research.
Full profile
Dr Giridhar Solasa, MD
Dr. Giridhar Solasa serves as Chief Protocol Officer and Communiqué Coordinator for Neuroscience20 Miami. A physician-scientist, Research Scientist and Program Officer with the Society for Brain Mapping and Therapeutics (SBMT), he works across scientific consortia, academic programs and international collaborations while advancing research in neurosurgery, neurotechnology and critical care.
Full profile

Dr. Pratiksha Baliga, MD
Dr. Pratiksha Baliga is an academic physician and neurosurgery researcher with clinical elective and fellowship experience at Hinduja Hospital, Sir H. N. Reliance Foundation Hospital & Research Centre, and SynapseSpine in India. Her work spans neurotrauma, neurocritical care, stroke, brain mapping, and translational neuroscience.
Full profile

Huitziliztli Negast
Huitziliztli Negast is Chief Research Intern at the Society for Brain Mapping and Therapeutics and an intern with the World Brain Mapping Foundation. Huitziliztli holds a Bachelor of Science in Neuroscience from the University of California, Santa Cruz, with interests in molecular and cellular biology, neuroscience, and research data analysis.
Full profile

Claire Mowry
Claire Mowry is an Honors Biological Sciences student at Florida State University on the premedical track and a research intern with the Society for Brain Mapping and Therapeutics. She also works in surgical services as a Patient Care Technician at HCA Florida Ocala Hospital, gaining hands-on experience in operating room readiness, patient safety, and coordination across clinical teams.
Full profile

Defne Şen
Defne Şen is an undergraduate student researcher at UCLA pursuing a Bachelor of Science in Microbiology, Immunology and Molecular Genetics. Her molecular biology research at Erbay Lab has examined the role of fragile X messenger ribonucleoprotein (FMRP) in atherosclerosis, with laboratory experience spanning lysosomal immunoprecipitation, siRNA transfection and studies of mitochondrial function and cellular senescence.
Full profile
Our Partners Help Move Global Brain Health Forward
Aramis Therapeutics
A Los Angeles-based biotechnology venture co-founded by Dr. Babak Kateb, focused on discovery and innovation across CellTech, BioTech, MedTech, AiTech, and PharmaTech for cancer and neurological disorders. It works to translate emerging neurotech and immuno-cellular therapeutics research into clinical applications, extending SBMT’s broader ecosystem of nanotechnology, cellular therapy, and imaging innovation into commercial development.
Visit official website
World Brain Mapping Foundation
Founded by Dr. Babak Kateb in 2004 alongside the Society for Brain Mapping and Therapeutics, WBMF funds SBMT members’ research and advances the cross-pollination of ideas between the physical sciences, biological sciences, and neuroscience. It has played a significant role in the national BRAIN Initiative and supports the National Center for NanoBioElectronics, integrating nanotechnology, cellular and stem cell therapy, medical devices, and imaging into brain health research.
Visit official website
Society for Brain Mapping and Therapeutics
A global multidisciplinary nonprofit founded in 2004 by Babak Kateb, Farzad Massoudi, and Warren Grundfest, uniting physicians, scientists, engineers, policymakers, and industry to advance brain and spinal cord mapping and image-guided therapeutics. Through its Annual Neurotech Convention and its role in Neuroscience20, SBMT brings together close to a thousand speakers each year across neurosurgery, psychiatry, oncology, ophthalmology, and neurotechnology to accelerate breakthroughs in brain health worldwide.
Visit official website
Uskudar University, Turkey
An Istanbul-based university under founding rector Prof. Kasif Nevzat Tarhan, recognized for its research in brain, behavioral, and health sciences. In partnership with SBMT, Uskudar University co-created the Global Consortium of Neurotech in Psychiatry, connecting faculty and researchers across Southern California, China, India, and Finland to study the brain’s impulse-regulatory mechanisms and the social and environmental factors that shape them.
Visit official websiteCelularity
A clinical and commercial-stage biotechnology company developing placental-derived cellular therapies and biomaterial products for serious unmet medical needs.
Visit official website
Moshayedi Ventures
Moshayedi Investment Group is a private investment firm led by founder and managing partner Dr. Kevan Moshayedi, MD, FACS. It backs early-stage and growth companies in healthcare and MedTech, AI and advanced technology, and telecommunications and infrastructure. Its investment focus spans Seed through Series D, including co-investments alongside established venture capital firms. Dr. Moshayedi brings more than 30 years of experience building and scaling companies across healthcare, telecommunications and advanced technology. His approach combines a physician's clinical insight, an engineer's technical expertise and an operator's experience to support founders and help bring transformative technologies to market.
Meet Dr. Kevan Moshayedi
The Neurobusiness Corporation
A Los Angeles-based neuroscience and applied AI company developing predictive digital twins of target consumers. Its neuromarketing research combines EEG, eye tracking, galvanic skin response (GSR) and ECG data to study attention, emotional response and consumer decision patterns. Its goal is to help brands make more evidence-based marketing and product decisions.
Founder & CEO: Arifa Kokab, MScEng, MMSc, MBA. N20 Selected Trailblazer and Panelist. Connect with Arifa on LinkedIn
Visit official website
Intelliforge.AI
Intelliforge.AI is the applied AI engineering and automation division of The Neurobusiness Corporation. It develops custom AI systems, human-governed agentic workflows and intelligent automation for organizations and research teams. Its technical work also connects computational neuroscience with emerging neurotechnology, including brain-computer interfaces and robotics.
Founder & CEO: Arifa Kokab, MScEng, MMSc, MBA. N20 Selected Trailblazer and Panelist. Connect with Arifa on LinkedIn
Visit official website
Federação Brasileira de Epilepsia (Epilepsia Brasil)
Federação Brasileira de Epilepsia (Epilepsia Brasil) connects patients, healthcare professionals, researchers and policymakers to advance epilepsy awareness, education, advocacy and scientific collaboration. Its mission includes reducing stigma, improving access to neurological care and encouraging innovation that responds to patients' needs.
As an N20 Miami partner, the Federation contributes a patient-centered perspective to international discussions on brain health, neurotechnology and public policy.
Visit official websiteCommuniqués, Legislations & Publications
Selected N20 communiqués, legislations, publications, resolutions and related official records. Each document is shown as a live preview and opens the official World Brain Mapping website document in a new tab.
N20 12th Annual Communiqué
Official N20 12th Annual Communiqué
N20 Turkey Communiqué
Official N20 Turkey report / communiqué
N20 Scientific Paper
G20 Brain Mapping Initiative position paper
N20 Brazil / G20 Social Document
G20 Social official invitation / document
N20 2019 Amendment Resolution
N20 2019 resolution record
Global G20 Brain & Spine Initiative Resolution
Neuroscience20 global resolution
Neuroscience20 JAD Publication Record
Published Neuroscience20 authors / JAD record
Nature Biotechnology - BRAIN Initiative / N20 Record
Published BRAIN Initiative / N20 record

Brazil: National Policy to Prevent Falls Among Older Adults
Translated summary: Brazil's Chamber of Deputies reported on Bill 4376/2024, which proposes a National Policy for Preventing Falls Among Older Adults. The proposal calls for personalized exercise programs, assessment and reduction of fall risks in health facilities and public/private spaces, accessibility and safety measures, annual awareness campaigns, national prevention protocols, and integrated care after a fall. Implementation would involve the Ministry of Health together with states, the Federal District and municipalities.
Blueprint of the Middle East Brain Initiative
Published through the Iranian Neurosurgical Society in 2015
N20 Special Discount Rates & Membership Prospectus
Explore membership, special discount rates and opportunities to partner with the 13th Annual Neuroscience20 Summit in the prospectus below.
About the Neuroscience20 Summit
Neuroscience20 (N20) is the global policy summit convening leaders in brain, spine, and mental health across G20 nations. N20 is a joint initiative of the Society for Brain Mapping & Therapeutics and the World Brain Mapping Foundation, combining SBMT’s scientific and clinical leadership with WBMF’s nonprofit mission of education, global collaboration, public awareness, patient impact and public-benefit brain health advancement.
The summit brings together policymakers, scientists, engineers, physicians, surgeons, universities, investors, and globally recognized research institutions to advance the development and deployment of clinical solutions for neurological disorders, conditions that affect more than three billion people and cost the global economy hundreds of billions of dollars annually.
Through this joint structure, N20 serves both as a high-level scientific and policy convening platform and as a mission-driven WBMF program supporting education, collaboration and patient-centered translation in brain, spine and mental health.
Connect with the Neuroscience20 Miami team
Share your interest in Neuroscience20 Miami 2026 and our team will route your request to the right contact for attendance, speaking, collaboration, financial partnership, donations or media follow-up.
Thirteen Years. Thirteen Cities. One Global Conversation.
The N20 Summit has convened across G20 capitals since 2014, driving cross-border policy alignment and translational research collaboration. Miami marks the 13th annual summit and the second U.S. host city in the program’s history.
Topics
Explore the official N20 Summit topics.
Official Summit Agenda Topics
Brain Mapping & Therapeutics
Imaging, connectivity, and image-guided intervention
Neurotechnology Innovation & Investment
The pipeline from lab to clinic, and the capital that moves it
Artificial Intelligence in Neuroscience
AI for diagnosis, imaging, and therapeutic decision support
Neuro-Imaging
Structural and functional imaging at clinical scale
Vascular Neurosurgery
Stroke, aneurysm, and cerebrovascular intervention
Neuro-Oncology
Brain tumor diagnosis, surgery, and combination therapy
Mental Health Disorders
Depression, anxiety, and major mental illness at scale
PTSD & Trauma
Post-traumatic stress across civilian and military populations
Suicide Prevention
Risk stratification, intervention, and policy frameworks
Opioid Addiction
The ongoing pandemic and neurobehavioral interventions
Epilepsy
Surgical, pharmacologic, and device-based approaches
Spine
Spinal disease, intervention, and rehabilitation
Neurodegenerative Disease
MS, ALS, Parkinson’s, and Alzheimer’s research
Traumatic Brain Injury (TBI)
Acute care, rehabilitation, and long-term outcomes
Spinal Cord Injury
Restoration, neuroprosthetics, and rehabilitation
Regulatory & Policy Frameworks
FDA, EMA, and cross-border neurotechnology policy
Enjoy the SBMT company rate at Pullman Miami Airport
Stay close to the summit with a preferred company booking offer for Society for Brain Mapping and Therapeutics travelers. Use the direct Accor reservation link below; the client and access codes are already included in the booking URL.